Skip to content

Efficacy of corticosteroids in minimally invasive treatment of pain in patients with type 2 diabetes mellitus

Efficacy of corticosteroids in minimally invasive treatment of pain in patients with type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077134
Enrollment
Unknown
Registered
2023-10-31
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain in elderly patients with comorbid type 2 diabetes mellitus

Interventions

Experimental group:The experimental group was treated with minimally invasive glucocorticoids (3.5 mg/m2= GCs < 7 mg/m2).
Control group:The control group was treated with minimally invasive glucocorticoids (GCs< 3.5 mg/m2).

Sponsors

Department of Pain Management,West China Hospital,Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed with type 2 diabetes mellitus comorbid chronic pain in the elderly (mainly including lumbar intervertebral disc herniation disease, cervical spondylosis, herpes zoster-related neuralgia). (2) Male or female, age > 65 years old, weight 45~75kg, disease course more than 3 months. (3) The coagulation function is normal, and there are no contraindications to puncture. (4) Good blood sugar control and no diabetes-related complications. (5) No history of hormone use within 3 months. (6) Have not participated in other clinical studies within 3 months.

Exclusion criteria

Exclusion criteria: (1) Type I diabetes. (2) Patients with glucocorticoid allergy. (3) Lesions at the puncture site: vertebral tumors, lumbar tuberculosis, spinal canal infection, huge protrusions in patients with lumbar intervertebral disc herniation, cauda equina syndrome, etc. (4) Severe cardiopulmonary insufficiency. (5) Patients with inflammation, infection and skin diseases at the puncture site. (6) Patients with organ dysfunction due to diabetes

Design outcomes

Primary

MeasureTime frame
visual analogue score ,VAS;Fasting blood glucose and blood glucose 2 hours postprandial time;

Secondary

MeasureTime frame
Adverse effects;Hospital stay;Hospital costs;Follow-up medication costs;

Countries

China

Contacts

Public ContactLing Ye

Department of Pain Management,West China Hospital,Sichuan University

zerodq_hx@163.com+86 189 8060 1894

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026